COMBINATI
LIVE

Serial Number

88106007

Owner

Combinati Incorporated

Attorney

Kenya L. Williams

First Use Date

Sep 2, 2020

Filing Date

Sep 5, 2018

Add to watchlist:

No watchlists yet
View on USPTO

COMBINATI Trademark

Serial Number: 88106007 • Registration: 6211661

COMBINATI is a trademark filed by Combinati Incorporated on September 5, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Combinati Incorporated (9 trademarks)

3436 Rambow Drive
Palo Alto, CA 94306

Entity Type: 03

Trademark Details

Filing Date

September 5, 2018

Registration Date

December 1, 2020

First Use Anywhere

September 2, 2020

First Use in Commerce

September 2, 2020

Published for Opposition

August 13, 2019

Goods & Services

Software for use in detecting cancer and infectious disease; software for use in prenatal screenings, namely, software for capturing optical images and performing image analysis; software for use in operating quantitative polymerase chain reaction (PCR) instruments; polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using polymerase chain reaction (PCR); scientific research instruments for use in measuring and quantifying copy number of DNA

Medical devices for detection of cancer; medical devices for detection of infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in detecting, diagnosing and treating cancer and infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital polymerase chain reaction (PCR) platform

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 17, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Dec 1, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 30, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 29, 2020 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2020 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Oct 8, 2020 SUPC
SOU EXTENSION 2 GRANTED
Oct 8, 2020 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 8, 2020 AITU
USE AMENDMENT FILED
Oct 5, 2020 IUAF
SOU EXTENSION 2 FILED
Oct 5, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 5, 2020 EEXT
TEAS STATEMENT OF USE RECEIVED
Oct 5, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 31, 2020 EXRA
SOU EXTENSION 1 GRANTED
Mar 27, 2020 EX1G
SOU EXTENSION 1 FILED
Mar 27, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 27, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 8, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 13, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 13, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 24, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2019 CRFA
ASSIGNED TO LIE
Jun 19, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 21, 2018 GNRN
NON-FINAL ACTION E-MAILED
Dec 21, 2018 GNRT
NON-FINAL ACTION WRITTEN
Dec 21, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 13, 2018 NWOS
NEW APPLICATION ENTERED
Sep 8, 2018 NWAP